PROGRAM CHAIRS
JoAnn V. Pinkerton, MD, MSCP, FACOG
Professor of Obstetrics and Gynecology
Division Director Midlife Health
The University of Virginia Health System
Charlottesville, VA
James A. Simon, MD, CCD, MSCP, IF, FACOG
Clinical Professor
George Washington University
IntimMedicine Specialists®
Washington, DC
PROGRAM OVERVIEW
This enduring activity is designed to assess the pathophysiological mechanism that results in vasomotor symptoms (VMS) due to menopause as well as evaluate both traditional and novel therapeutic options for treatment. Effective communication strategies for patient/physician interactions and possible barriers to communication will also be discussed.
TARGET AUDIENCE
This enduring activity is designed to meet the educational needs of U.S.-based obstetrician-gynecologists, primary care physicians, including internists, family practitioners, nurse practitioners, physician assistants, nurses, and additional healthcare providers who treat menopausal women.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Assess the pathophysiological mechanisms that result in VMS due to menopause
- Evaluate traditional treatment options for patients with VMS due to menopause
- Develop strategies that allow for effective communication with patients on issues and challenges associated with VMS due to menopause
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in this enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| JoAnn V. Pinkerton, MD, MSCP, FACOG | Dr. Pinkerton discloses that she has conducted research for PI Multicenter Bayer Nonhormone Clinical Trial Fees to the University of Virginia. Dr. Pinkerton is an UpToDate and Merck Professional and Consumer. |
| James A. Simon, MD, CCD, MSCP, IF, FACOG | Dr. Simon discloses that he has conducted research for AbbVie, Bayer Healthcare, Dare Bioscience, Ipsen, Mylan/Viatris, Myovant Sciences, and Sebela Pharmaceuticals. He holds stock with a direct purchase plan in Sermonix Pharmaceuticals. He is a consultant for Bayer HealthCare Pharmaceuticals, Besins Healthcare, Biote Medical, California Institute of Integral Studies (CIIS), Dare Bioscience, and Femasys. He is on speakers Bureaus for Astellas Pharma, Mayne Pharma, Myovant Sciences, Pfizer, Pharmavite, and Scynexis. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Mike Milano, MD, discloses that he receives royalties from Wolters Kluwer.
- Anne Knieriem, RN, MSN, has nothing to disclose.
- Nicole Love-Grove, D.O., has nothing to disclose.
- Deborah Anderson, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator, for Med Learning Group, has nothing to disclose.
- Jacquelyn Sandfort, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: May 30, 2024
EXPIRATION DATE: May 30, 2025
Copyright ©2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
